Bangalore, 24 January 2018: Navitas Life Sciences, as a Gold Sponsor, participated at the 11th Annual conference themed “Collaborative Clinical Research for better Patient outcomes” from 19 - 20 January 2018. The two-day event, preceded by pre-conference workshops, saw over 800 clinical research professionals from across the globe deliberate on the collaborative role required of clinical research stakeholders in a strengthened and improved clinical research regulatory environment.
Speaking at the conference, Ram Yeleswarapu, President, TAKE Solutions Limited said, “On behalf of the global Navitas Life Sciences team I would like to thank Indian Society for Clinical Research (ISCR) for this fantastic opportunity. This is a great experience to be at the forefront of clinical research development, to hear about the innovations, new found mechanisms and investments that are happening. As a company, we are truly proud to be partners at this conference.”
Navitas Life Sciences helps biopharmaceutical companies address their most critical problems by bringing together the capabilities of a full-service CRO, a technology-led life sciences services provider across clinical, regulatory and safety, and a life sciences big data services and analytics provider. Navitas Life Sciences has delivered 330+ Phase II-III Clinical studies and over 400 Non-Interventional Studies across multiple therapeutic areas including Oncology, Endocrinology, Metabolic, Ophthalmology, Cardiovascular, Respiratory, Dermatology, Neurology, etc.
Navitas’ clinical trials capabilities are augmented by OneClinical, an optimized eClinical and Analytics platform that offers comprehensive trial oversight. OneClinical ensures faster and better-informed decision making for successful outcomes. It incorporates quality by design, delivering effective oversight of trials and provides actionable insights through comprehensive data visualization.
About Indian Society for Clinical Research (ISCR)
The Indian Society for Clinical Research (ISCR) is an association of Indian clinical research professionals. The Society brings together all those who are engaged in clinical research activities in India and provides a forum for exchange of information and learning. ISCR aims to build awareness of clinical research as a specialty in India and to facilitate its growth in the country while helping to evolve the highest standards of quality and ethics.
More information: http://www.iscr.org/
About Navitas Life Sciences
As a partner for the industry, Navitas Life Sciences leverages industry insights, consulting and technology capabilities to deliver full service clinical, regulatory and safety solutions and desired outcomes to clients. As the dedicated life sciences brand of TAKE Solutions, Navitas harnesses the combined knowledge and experience of three legacy brands—Ecron Acunova, Navitas, and Intelent—to provide end-to-end services and solutions. Navitas helps clients address their most critical problems by bringing together the capabilities of a full-service CRO, a technology-led life sciences services provider across clinical, regulatory and safety, and a life sciences big data services and analytics provider. Operating from 7 countries across the globe, Navitas works with over 150 customers in Life Sciences.
To learn more, visit www.navitaslifesciences.com.
About TAKE Solutions
TAKE Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management.
In the fast-growing Life Sciences space, TAKE offers clients a unique combination of a full-service CRO backed by industry insights and technology expertise. Our range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through our proprietary industry networks. With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers outcomes for clients, including 9 of the top 10 global pharmaceutical companies.
In Supply Chain Management, TAKE focuses on high-margin niches in engineering, mobility and collaboration. Our IP-led approach enables our clients to automate supply chain processes, track, trace & control at item level, extend mobility, mandate supplier compliance, and streamline material & shipment movement, and thus optimize their processes.
With operations spread across North America, Europe, Asia, and South America, TAKE is a Public Company, listed in India on the Bombay Stock Exchange and the National Stock Exchange. Led by a team of industry stalwarts and domain experts, TAKE has been growing steadily with FY17 revenues touching INR 13,520 Mn, a 29% increase year-on-year. For more information, please visit www.takesolutions.com.